Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

GEMINI · Towards GEMINI: A Generation of Multi-scale Digital Twins of Ischaemic and Haemorrhagic Stroke Patients

HORIZONStatus: SIGNED1 December 202330 November 2029EU funding €9,991,878Call HORIZON-HLTH-2023-TOOL-05

GEMINI aims to deliver validated multi-organ and multi-scale computational models for treatment decision support and improved fundamental understanding of acute strokes, both ischaemic and haemorrhagic. We will demonstrate the added benefit of these computational models in personalised disease management. Specifically, GEMINI will deliver validated, integrated multi-scale, multi-organ Digital Twin in Healthcare (DTH) models for cerebral blood and cerebrospinal fluid flow, brain perfusion and metabolism, and blood flow and thrombosis along the heart-brain axis by integrating available and newly developed dynamic, interoperable, and modular computational models. Building on these models, GEMINI will deliver validated population-based DTHs of ischemic and haemorrhagic stroke aetiology and onset, treatment, and disease progression. Utilising these population-based DTHs, GEMINI will validate five personalised subject-specific DTHs, (1) stroke treatment, and (2) disease progression DTHs for acute ischaemic stroke and (3) aneurysm treatment, (4) subarachnoid haemorrhage progression, and (5) unruptured intracranial aneurysm risk assessment DTHs for haemorrhagic stroke to guide patient care and long-term management. We will bring proof of value of digital twins by the evaluation of the ischaemic stroke treatment selection DTH in a multi-centre clinical trial, in which treatment and patient outcomes are compared in situations with and without the availability of a DTH. GEMINI will implement a project-wide structured approach for data harmonisation, curation, model validation, verification, and model certification of the DTHs. Several outcomes of GEMINI have a high value for clinical practice, medical device industry, and in enhancing research in the fields of (bio)medical and computer sciences, warranting an extensive valorisation strategy with adequate IP protection and versatile exploitation actions to enhance a wide adaptation of the results of GEMINI.

Consortium · 22 organisations

coordinator

STICHTING AMSTERDAM UMC

NL · €2,962,670

participant

UNIVERSIDAD POMPEU FABRA

ES · €532,500

participant

UNIVERSITY OF GALWAY

IE · €603,858

participant

AKADEMIA GORNICZO-HUTNICZA IM. STANISLAWA STASZICA W KRAKOWIE

PL · €443,750

participant

SIM&CURE

FR · €281,250

participant

SANO CENTRUM ZINDYWIDUALIZOWANEJ MEDYCYNY OBLICZENIOWEJ MIEDZYNARODOWA FUNDACJA BADAWCZA

PL · €532,500

participant

BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM

HU · €537,250

associatedPartner

UNIVERSITY OF CAPE TOWN

ZA

associatedPartner

NATIONAL TAIWAN UNIVERSITY

TW

participant

RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITAT BONN

DE · €406,250

participant

NEURAVI LIMITED

IE · €603,750

associatedPartner

LES HOPITAUX UNIVERSITAIRES DE GENEVE

CH

participant

POLITECNICO DI MILANO

IT · €587,500

participant

INSTEPS BV

NL · €162,500

thirdParty

AMSTERDAM UMC RESEARCH BV

NL

participant

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

NL · €553,885

associatedPartner

CRANFIELD UNIVERSITY

UK

associatedPartner

ZURCHER HOCHSCHULE FUR ANGEWANDTE WISSENSCHAFTEN

CH

participant

ANSYS FRANCE SAS

FR · €299,000

participant

NICO-LAB BV

NL · €280,610

participant

TECHNISCHE UNIVERSITEIT DELFT

NL · €337,605

participant

UNIVERSITEIT VAN AMSTERDAM

NL · €867,000

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.